PUBLIC CONTRACT · 2022
Medicamentos foro oncológico
- Contract value
- €381,289.20
- Signed on
- 6 January 2022
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9291942PUBLISHED SUBJECT
41/347/2022 Medicamentos foro oncológico
Parties involved
- Awardee
- BDRPHARMA, LDA; AMGEN - BIOFARMACÊUTICA, LDA.; Astra Zeneca; Takeda - Farmacêutica Portugal, Lda; BOEHRINGER INGELHEIM PORTUGAL LDA
- Place of performance
- Portugal, Faro, Faro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- BDRPHARMA, LDA · Tax ID 513077332
- Awardee
- AMGEN - BIOFARMACÊUTICA, LDA. · Tax ID 502942959
- Awardee
- Astra Zeneca · Tax ID 502942240
- Awardee
- Takeda - Farmacêutica Portugal, Lda · Tax ID 502801204
- Awardee
- BOEHRINGER INGELHEIM PORTUGAL LDA · Tax ID 500293023
Values and timeline
- Contract price
- €381,289.20
- Procedure base price
- €0.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 1 June 2022
- Award date
- 6 January 2022
- Signing date
- 6 January 2022
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2021/6 - Medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5939808
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.